111 Cost of Goods Sold 2018-2024 | YI
111 cost of goods sold from 2018 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
| 111 Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $1,986 |
| 2022 | $1,838 |
| 2021 | $1,852 |
| 2020 | $1,201 |
| 2019 | $544 |
| 2018 | $245 |
| 2017 | $131 |
| 111 Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-09-30 | $483 |
| 2024-06-30 | $443 |
| 2024-03-31 | $460 |
| 2023-12-31 | $555 |
| 2023-09-30 | $476 |
| 2023-06-30 | $451 |
| 2023-03-31 | $504 |
| 2022-12-31 | $531 |
| 2022-09-30 | $442 |
| 2022-06-30 | $425 |
| 2022-03-31 | $440 |
| 2021-12-31 | $533 |
| 2021-09-30 | $494 |
| 2021-06-30 | $448 |
| 2021-03-31 | $378 |
| 2020-12-31 | $439 |
| 2020-09-30 | $335 |
| 2020-06-30 | $218 |
| 2020-03-31 | $210 |
| 2019-12-31 | $187 |
| 2019-09-30 | $149 |
| 2019-06-30 | $116 |
| 2019-03-31 | $93 |
| 2018-09-30 | $70 |
| 2018-06-30 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.072B | $2.105B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.709B | 54.09 |
| Hims & Hers Health (HIMS) | United States | $11.210B | 183.25 |
| Tempus AI (TEM) | United States | $10.954B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.532B | 107.78 |
| IRhythm Technologies (IRTC) | United States | $3.734B | 0.00 |
| Privia Health (PRVA) | United States | $2.941B | 245.10 |
| Enovis (ENOV) | United States | $2.475B | 16.49 |
| Clover Health Investments (CLOV) | United States | $2.095B | 0.00 |
| Azenta (AZTA) | United States | $2.083B | 96.98 |
| Omnicell (OMCL) | United States | $1.845B | 40.23 |
| Schrodinger (SDGR) | United States | $1.580B | 0.00 |
| Phreesia (PHR) | United States | $1.577B | 0.00 |
| 10x Genomics (TXG) | United States | $1.381B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.859B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.512B | 0.00 |
| Standard BioTools (LAB) | United States | $0.495B | 0.00 |
| Talkspace (TALK) | United States | $0.481B | 285.00 |
| TruBridge (TBRG) | United States | $0.423B | 123.26 |
| Nyxoah SA (NYXH) | Belgium | $0.353B | 0.00 |
| Pulmonx (LUNG) | United States | $0.352B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.305B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.257B | 0.00 |
| American Well (AMWL) | United States | $0.174B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.085B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| CareCloud (CCLD) | United States | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |